Brain Tumor Clinical Trials

Find Brain Tumor Clinical Trials Near You

Prospective Randomized Controlled Trial of Skin Closure Techniques in Oncological Cranial Neurosurgery: Interrupted Transdermal Sutures and Running Intradermal Suture.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to compare two commonly used methods of closing the skin after surgery for an intracranial tumor. Skin closure is one of the most important steps in neurosurgical procedures, as it has a major influence on how well the wound heals. In patients with brain tumors, proper wound healing is especially important because it may affect how soon additional treatments, such as radiotherapy or chemotherapy, can be started. There are different ways to close the skin after surgery, including running sutures and interrupted sutures. Both methods are widely used and considered safe. However, in oncological neurosurgery, there is limited scientific evidence comparing their effects, and the choice of technique is often based on the surgeon's personal experience. In this study, investigators will compare skin closure using running absorbable sutures with interrupted non-absorbable sutures. Investigators will evaluate how well, depending on used suturing methods, the wound heals and how often wound-related complications occur, such as infection, separation of the wound edges, or leakage of cerebrospinal fluid. Investigators believe that the results of this study will help improve wound care in patients undergoing neurosurgical treatment for brain tumors and, as a result, may contribute to better recovery and overall quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female at least 18 years old

• Qualified for a craniotomy due to supratentorial intracranial tumor

Locations
Other Locations
Poland
Department of Neurosurgery of Medical University of Warsaw
RECRUITING
Warsaw
Contact Information
Primary
Michał Senger, M.D.
michal.senger@wum.edu.pl
+48 791 760 040
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2028-05
Participants
Target number of participants: 382
Treatments
Experimental: Subjects receiving absorbable running intradermal sutures
Active_comparator: Subjects receiving non-absorbable interrupted transdermal sutures
Sponsors
Leads: Medical University of Warsaw

This content was sourced from clinicaltrials.gov